AP
TECH icon

Advisor Partners’s Bio-Techne TECH Stock Holding History

Advisor Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$288K Sell
3,320
-1,216
-27% -$114K 0.02% 652
2022
Q1 		$491K Buy
4,536
+1,492
+49% +$154K 0.03% 520
2021
Q4 		$394K Buy
3,044
+312
+11% +$38.2K 0.02% 585
2021
Q3 		$331K Sell
2,732
-372
-12% -$45.3K 0.02% 614
2021
Q2 		$349K Buy
3,104
+68
+2% +$7.16K 0.02% 610
2021
Q1 		$290K Buy
3,036
+44
+1% +$4.01K 0.02% 644
2020
Q4 		$238K Buy
+2,992
New +$217K 0.02% 654

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Advisor Partners's TECH Position: Q2 2022 in Review

Advisor Partners reduced its Bio-Techne (TECH) stake by 27% in Q2 2022, selling an estimated $114K and leaving 3,320 shares worth $288K. The position accounts for 0.02% of the portfolio, ranked #652.

Advisor Partners first reported a position in TECH in Q4 2020 and has held it in 7 quarters since. The position peaked at $491K in Q1 2022. 550 funds tracked by Wall St. Rank hold TECH as of Q2 2022.

  • Advisor Partners held 3,320 shares of Bio-Techne worth $288K as of Q2 2022.
  • Advisor Partners sold 1,216 Bio-Techne shares in Q2 2022, an estimated $114K.
  • Bio-Techne made up 0.02% of Advisor Partners's portfolio in Q2 2022, its #652 holding.
  • Advisor Partners first reported a position in Bio-Techne in Q4 2020 and has held it in 7 quarters since.
  • Advisor Partners's Bio-Techne position peaked at $491K in Q1 2022.
  • 550 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2022.

Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.